News & Press Releases
Whistleblowers Critical to Combat Electronic Health Records Fraud
A Synopsis of Will Powers’ Article in Medium.com on April 5, 2019 Medical organizations adopting electronic health records (EHR) technology have been awarded millions of [...]
Actelion Agrees to Pay $360 Million for Improperly Funneling Kickbacks into Patient Assistance Program (PAP)
Johnson & Johnson acquisition Actelion recently became the latest drug maker to land in the crosshairs of the Department of Justice (DOJ) for the improper [...]
Whistleblowers Play Key Role in Identifying Fraudulent Patient Assistance Programs
Are you one of the many physicians, caregivers, therapists and patients attending this week’s Patient Assistance Programs conference in Baltimore, Maryland? If so, then please [...]
HUBZone program has become a prime target for fraud
In a commentary piece published by Washington Technology, Baron & Budd Attorney Andrew Miller talks about how the HUBZone program has become a prime target [...]
Baron & Budd Investigates Potential Fraud Activity Among HUBZone-Certified Small Businesses
HUBZone contractors play key role in policing industry, identifying and reporting potential fraud October 8, 2018, Washington D.C. - Today, the national law firm Baron & Budd [...]
Whistleblowers Exposing the Other Side of Patient Assistance Programs
It sounds great on the surface. Pharmaceutical companies contribute hundreds of millions of dollars to organizations that work to make incredibly expensive, life-saving drugs more [...]
Baron & Budd Investigating Medicare and Medicaid Fraud in Patient Assistance Programs for Specialty Drugs
Whistleblowers play key role highlighting fraudulent charities that target public insurance programs September 24, 2018 WASHINGTON -- Today, the national law firm Baron & Budd [...]
Baron & Budd Secures $110 Million to Settle Texas Whistleblower Lawsuits Against AstraZeneca for Fraudulently Marketing Seroquel, Crestor
Suits Alleged Pharmaceutical Giant Illegally Promoted Seroquel Prescriptions for Children, Misrepresented Safety of Crestor August 07, 2018 DALLAS--(BUSINESS WIRE)--Today, the national law firm of Baron & Budd announced [...]
Baron & Budd Secures $13.25 Million to Settle Texas Whistleblower Lawsuit Against Endo Pharmaceuticals for Fraudulently Marketing Lidoderm for Unapproved UsesBaron & Budd Secures $13.25 Million to Settle Texas Whistleblower Lawsuit Against Endo Pharmaceuticals for Fraudulently Marketing Lidoderm for Unapproved Uses
Baron & Budd Secures $13.25 Million to Settle Texas Whistleblower Lawsuit Against Endo Pharmaceuticals for Fraudulently Marketing Lidoderm for Unapproved Uses
Pharmaceutical Company Allegedly Violated Federal and Texas Medicaid Laws August 01, 2018 DALLAS--(BUSINESS WIRE)--Today, the national law firm of Baron & Budd announced that Endo Pharmaceuticals Inc. (“Endo”) [...]
